Antipsychotic Drugs Market to Hit USD 33.69 Billion by 2028; Stoked by Growing Awareness Regarding Psychotic Disorders, states Fortune Business Insights™
Request a Sample Copy of the Research Report:
This report focuses on Antipsychotic Drugs Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered complete lockdown of industrial and human activities. This is expected to have a significant impact on the market in 2021. However, proactive steps by the industry leaders to revive the Healthcare industry will bode well for the growth of the market in the near future.
The negative effect of the global pandemic, COVID-19, has been felt across several economies facing unprecedented loss. Owing to the lockdown announced by the government agencies, several industries have been at a standstill with limited operational activities. However, a collective effort from the government and the industries is likely to bring the economy back on track and aid in the resumption of industrial activities.
Based on disease, the market is segmented into schizophrenia, bipolar disorder, unipolar depression, dementia, and others.
• On the basis of disease, the schizophrenia segment held a global antipsychotic drugs market share of about 45.2% in 2020 and is expected to gain traction during the foreseeable years. This is due to the increasing prevalence of schizophrenia among people globally. Moreover, supportive government initiatives to create awareness regarding the treatment options for mental issues are expected to bode well for the adoption of innovative drugs.
Based on therapeutic class, the market is classified into first generation, second generation, and third generation. On the basis of the distribution channel, the market is categorized into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. Lastly, based on the region, the market is divided into North America, the Middle East and Africa, Latin America, Europe, and Asia-Pacific.
What does the Report Provide?
The global market report provides a detailed analysis of several factors, such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will further contribute to the market growth. Moreover, the research analyst has adopted several research methodologies such as PORTER’s Five Point Analysis and PESTEL to obtain information about the current trends and industry developments that will drive the market growth between 2021 and 2028.
Quick Buy - Antipsychotic Drugs Market Research Report:
Increasing Awareness Regarding Psychotic Disorders to Aid Growth
According to the American Psychiatric Association (APA), about 1 in 24 patients in 2018 suffered from serious mental disorders involving serious psychotic disorders. The growing prevalence of mental disorders exerts a huge burden on the healthcare system. Therefore, the government is focusing on creating awareness regarding the diseases and the efficacy of the drugs involved in their treatment. This has led to significant demand for highly efficient and safe drugs to treat patients suffering from psychotic diseases across the globe. Moreover, the companies are focusing on launching innovative antipsychotic injectable drugs that help eliminate the need to monitor the patient’s drug intake. This is anticipated to favor the global antipsychotic drugs market growth in the forthcoming years.
North America – The region is expected to remain at the forefront during the forecast period. This is ascribable to factors such as the growing focus on R&D by prominent biopharmaceutical companies to develop advanced antipsychotic drugs in the region. North America stood at USD 11.62 billion in 2020.
Europe – The region is expected to hold the second position in the market during the forecast period. This is owing to the increasing prevalence of mental disorders that are propelling the demand for several antipsychotic drugs in the region. For instance, according to the Mental Health First Aid England (MHFA), mental illness is the second-largest source of healthcare burden in England as of 2020.
Major Companies Focus on Expanding Their Facilities to Expand Their Business Horizon
The global market comprises small, medium, and large companies. They are striving to maintain their business footprint by expanding their production facilities to cater to the growing demand for innovative antipsychotic drugs. Additionally, the adoption of strategies such as partnership, collaboration, and merger and acquisition by other key players is expected to bode well for the growth of the market.
Have Any Query? Ask Our Experts:
• June 2020 – Sumitomo Dainippon Pharma’s atypical antipsychotic agent, LATUDA tablets were launched in Japan. The introduction of the drug is expected to strengthen the company’s position in the country.
List of the Companies Profiled in the Market:
• H. Lundbeck A/S (Copenhagen, Denmark)
• Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)
• Janssen Pharmaceuticals, Inc. (Johnson & Johnson) (Beerse, Belgium)
• Eli Lilly and Company (Indianapolis, U.S.)
• ALLERGAN (AbbVie, Inc.) (North Chicago, U.S.)
• Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)
• Dr. Reddy’s Laboratories Ltd. (Hyderabad, India)
• Sumitomo Dainippon Pharma Co., Ltd. (Osaka, Japan)
• Alkermes plc (Dublin, Ireland)
• Bristol-Myers Squibb Company (New York City, U.S.)
• Other Prominent Players
Table Of Contents :
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
• Key Insights
o Prevalence of Psychiatric Disorders, By Key Countries/Regions, 2020
o Analysis of the Cost and Burden of Mental Health Disorders
o Pipeline Analysis
o Overview of Current Advances in R&D for Antipsychotic Drugs
o Analysis of Antipsychotics in Treatment of Dementia
o Analysis: First Generation Antipsychotics vs. Third Generation Antipsychotics
o Key Industry Developments
o New Product Launches
o Impact of COVID-19 on Antipsychotic Drugs Market
• Global Antipsychotic Drugs Market Analysis, Insights and Forecast, 2017-2028
o Key Findings / Summary
o Market Analysis, Insights and Forecast– By Disease
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/antipsychotic-drugs-market-101390
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:
• Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
• Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
• Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
• Number of procedures and average price of procedures
• Replacement rate and pricing of capital equipment
• Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
• Market & technological trends, new product developments, product pipeline.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune - 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Fortune Business Insights™
LinkedIn | Twitter | Blogs
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antipsychotic Drugs Market to Hit USD 33.69 Billion by 2028; Stoked by Growing Awareness Regarding Psychotic Disorders, states Fortune Business Insights™ here
News-ID: 2368709 • Views: 225
More Releases from Fortune Business Insights
Immunoglobulin Market to Reach USD 18,378.0 Million by 2025; FDA Approval for AD …
Market Overview: The global immunoglobulin market size is expected to reach USD 18,378.0 million by 2025 exhibiting a CAGR of 7.0% during the forecast period. The increasing diagnosis rates owing to escalating awareness regarding the treatment of immunoglobulins will have a tremendous effect on the market during the forecast period, states Fortune Business Insights in a report, titled “Immunoglobulin Market Size, Share and Industry Analysis By Route of Administration (Intravenous (IV),
Life Science Instrumentation 2021 Global Market Research report covers a detaile …
Global Life Science Instrumentation market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Life Science Instrumentation Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Life Science Instrumentation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels
Hospital Acquired Infections Treatment 2021 Global Market Research report covers …
Global Hospital Acquired Infections Treatment market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Hospital Acquired Infections Treatment Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Hospital Acquired Infections Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and
Anti-Inflammatory Biologics Market 2021-2026 Study & Future Prospects Including …
Anti-Inflammatory Biologics Market | 2021 Global Industry Forecast To 2026, is latest report on Global Anti-Inflammatory Biologics Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Anti-Inflammatory Biologics Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Anti-Inflammatory Biologics is to hit USD 149.80 billion value by 2027 at CAGR of 11.0%. Report segments Anti-Inflammatory Biologics Market By Drug Class (Anti-Tumor
More Releases for Antipsychotic
Antipsychotic Medications Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Antipsychotic Medications market. Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-antipsychotic-medications-market_p103541.html Global Antipsychotic Medications Market: Forecast by Type / Application / Region The worldwide market for Antipsychotic Medications is expected to
Antipsychotic Drugs Market, by Drug Type, Application, Distribution Channel
Anti-psychotic drugs, also called tranquilizers or neuroleptics, are a specific type of medication that are majorly used for the treatment of schizophrenia or bipolar disorder. They are used to manage psychosis, including hallucinations, delusions, and disordered thought of paranoia, among others. Anti-psychotic drugs are effective for the treatment of psychosis in a short duration. These drugs block the dopamine receptors in the dopaminergic pathways of the brain, thereby repressing the
Antipsychotic Drugs Market Enhancement in Medical Sector 2025
This report studies the global Antipsychotic Drugs market, analyzes and researches the Antipsychotic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline … Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/100987 Market segment by Regions/Countries, this report covers United States,EU,Japan,China,India,Southeast Asia Market segment by Type, the product can
A Comprehensive Research exploring Antipsychotic Drugs Market
HTF MI recently introduced Global Antipsychotic Drugs Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2022. At present, the market is developing its presence and some of the key players from the complete study are Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca & GlaxoSmithKline etc. The market Study is segmented by key regions which is accelerating the
Antipsychotic Drugs Market - Prominent Players,Growth and Forecast 2016 - 2024
Global Antipsychotic Drugs Market: Overview The global market for antipsychotic drugs is witnessing significant traction owing to the global rise in prevalence of psychotic disorders such as bipolar disorder, schizophrenia, delusions, hallucinations, and very severe depression (called “psychotic depression”). Recent studies have stated that antipsychotics are one of the top-selling and most widely prescribed drugs for managing psychotic conditions in the United States. Although earlier prescribed only for such psychotic conditions,
Global Antipsychotic drugs Detailed Analysis Report 2017-2022
This report splits Antipsychotic drugs by Product Antipsychotic drugs, Product Antidepressant anti-anxiety drugs. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antipsychotic drugs industry. Major Companies